ABEONA THERAPEUTICS INC. Other Assets
ABEONA THERAPEUTICS INC. (ABEO) had Other Assets of $139.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets
us-gaap:OtherAssets · last filed 2023-11-13
- 2023-09-30: Other Assets $139.00K.
- 2023-06-30: Other Assets $108.00K.
- 2023-03-31: Other Assets $99.00K.
- 2022-12-31: Other Assets $43.00K.
| Period end | Other Assets |
|---|---|
| 2023-09-30 | $139.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $108.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $99.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $43.00K 10-Q · filed 2023-11-13 |
| 2021-12-31 | $168.00K 10-K · filed 2023-03-29 |
| 2017-09-30 | $77.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $66.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $66.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $66.00K 10-Q · filed 2017-11-14 |
| 2016-09-30 | $66.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $108.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $102.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $62.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $62.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $42.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $41.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $32.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $32.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $32.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $32.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $32.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $42.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $42.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $42.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $42.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | $46.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $51.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $55.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $59.00K 10-K · filed 2013-03-20 |
| 2010-12-31 | $44.00K 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |